We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.7B
AUM Growth
+$144M
Cap. Flow
+$80.4M
Cap. Flow %
1.2%
Top 10 Hldgs %
21%
Holding
1,675
New
169
Increased
710
Reduced
579
Closed
127

Sector Composition

Rank Sector Weight
1 Technology 21.11%
2 Financials 10.66%
3 Industrials 8.29%
4 Consumer Discretionary 7.5%
5 Healthcare 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALB.PRA icon
1101
Albemarle Corp Depositary Shares
ALB.PRA
$2.23B
$454K 0.01%
11,160
+1,460
+15% +$67.5K
CCEP icon
1102
Coca-Cola Europacific Partners
CCEP
$49.1B
$452K 0.01%
5,888
+1,571
+36% +$121K
CRSP icon
1103
CRISPR Therapeutics
CRSP
$4.69B
$452K 0.01%
11,480
-22,648
-66% -$1.07M
EWBC icon
1104
East-West Bancorp
EWBC
$17.8B
$450K 0.01%
4,700
-2,412
-34% -$237K
AROC icon
1105
Archrock
AROC
$6.16B
$449K 0.01%
+18,038
New +$418K
IXN icon
1106
iShares Global Tech ETF
IXN
$7.87B
$449K 0.01%
5,296
+76
+1% +$6.38K
EXG icon
1107
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.91B
$448K 0.01%
54,847
+16,117
+42% +$136K
CCL icon
1108
Carnival Corporation Ltd
CCL
$38.1B
$448K 0.01%
+17,969
New +$421K
INFL icon
1109
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.49B
$447K 0.01%
+11,749
New +$470K
BMO icon
1110
Bank of Montreal
BMO
$123B
$446K 0.01%
4,597
-65
-1% -$6.14K
IHE icon
1111
iShares US Pharmaceuticals ETF
IHE
$1.49B
$446K 0.01%
6,786
IDCC icon
1112
InterDigital
IDCC
$6.75B
$446K 0.01%
+2,300
New +$402K
L icon
1113
Loews
L
$24.5B
$444K 0.01%
5,246
EMXC icon
1114
iShares MSCI Emerging Markets ex China ETF
EMXC
$22.1B
$442K 0.01%
7,963
-7,308
-48% -$429K
EIX icon
1115
Edison International
EIX
$30.3B
$441K 0.01%
5,528
FLNG icon
1116
FLEX LNG
FLNG
$1.69B
$439K 0.01%
+19,134
New +$464K
SHYG icon
1117
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.6B
$436K 0.01%
10,239
-567
-5% -$24.4K
DHT icon
1118
DHT Holdings
DHT
$2.99B
$435K 0.01%
+46,777
New +$481K
EVT icon
1119
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.06B
$433K 0.01%
18,002
+8,018
+80% +$198K
ROST icon
1120
Ross Stores
ROST
$80.8B
$431K 0.01%
2,847
+524
+23% +$77K
DG icon
1121
Dollar General
DG
$28.4B
$428K 0.01%
5,648
+2,534
+81% +$200K
TTMI icon
1122
TTM Technologies
TTMI
$10.6B
$423K 0.01%
17,100
+1,000
+6% +$22.7K
NSA
1123
DELISTED
National Storage Affiliates Trust
NSA
$422K 0.01%
11,128
+3,935
+55% +$169K
NN icon
1124
NextNav
NN
$1.79B
$420K 0.01%
27,000
+17,000
+170% +$226K
ACLS icon
1125
Axcelis
ACLS
$3.44B
$420K 0.01%
6,007
+1,307
+28% +$109K

Similar funds

Oppenheimer & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Oppenheimer & Co held 1,675 positions worth $6.7B, up 2.2% from $6.56B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q4 2024 filing shows 169 new, 710 increased, 579 reduced and 127 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M. The largest sale was FT Vest US Equity Deep Buffer ETF March, an estimated $21.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q4 2024 buy was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M.
  • Oppenheimer & Co added most to iShares Russell Mid-Cap Growth ETF in Q4 2024, an estimated $12.8M increase.
  • Oppenheimer & Co's biggest Q4 2024 reduction was FT Vest US Equity Deep Buffer ETF March, cutting an estimated $21.8M.
  • Oppenheimer & Co fully exited Innovative Industrial Properties in Q4 2024, selling an estimated $6.32M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $6.7B portfolio in Q4 2024.
  • Oppenheimer & Co opened 169 new positions and closed 127 in Q4 2024.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $6.7B.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.